Therapeutic Potential of FXI Inhibitors: Hype or Hope?
Mattía Galli, Giovanni Occhipinti, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Salvatore Brugaletta, Davide Capodanno, Sebastiano Sciarretta, Dominick J. Angiolillo
Topics & Concepts
MedicineApixabanIntensive care medicineHemostasisAtrial fibrillationClinical trialMyocardial infarctionInternal medicineRivaroxabanWarfarinCoagulation, Bradykinin, Polyphosphates, and AngioedemaBlood Coagulation and Thrombosis MechanismsPeptidase Inhibition and Analysis